Benitec Biopharma Inc. (NASDAQ:BNTC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 12, 2026.
The Healthcare company reported Q0 revenue of .
Benitec Biopharma Inc.'s stock currently trades at $11.34 with a market capitalization of $339.6M.
